Compare UAL & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UAL | A |
|---|---|---|
| Founded | 1934 | 1999 |
| Country | United States | United States |
| Employees | 117500 | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1B | 38.0B |
| IPO Year | 1996 | 1999 |
| Metric | UAL | A |
|---|---|---|
| Price | $115.35 | $139.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 15 |
| Target Price | $130.12 | ★ $161.47 |
| AVG Volume (30 Days) | ★ 5.1M | 1.6M |
| Earning Date | 04-21-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | ★ 7.94 | 3.16 |
| EPS | ★ 4.60 | 2.27 |
| Revenue | ★ $37,736,000,000.00 | $4,472,000,000.00 |
| Revenue This Year | $11.70 | $8.45 |
| Revenue Next Year | $5.06 | $6.13 |
| P/E Ratio | ★ $25.49 | $58.79 |
| Revenue Growth | 3.23 | ★ 6.43 |
| 52 Week Low | $82.42 | $108.35 |
| 52 Week High | $138.77 | $160.27 |
| Indicator | UAL | A |
|---|---|---|
| Relative Strength Index (RSI) | 37.61 | N/A |
| Support Level | $110.69 | N/A |
| Resistance Level | $118.01 | N/A |
| Average True Range (ATR) | 4.18 | 0.00 |
| MACD | -2.28 | 0.00 |
| Stochastic Oscillator | 1.48 | 0.00 |
Chicago-based United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel, especially across the Pacific, than its large US peers.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.